From the lab to the factory

How do you take a successful bioavailability solution from the laboratory to the pilot plant and on to commercial-scale production? What are the potential pitfalls and considerations involved in successfully scaling-up the production of a poorly soluble API?

Clare Rawlinson Malone, Senior Research Investigator, Bristol-Myers Squibb

Moderator: Dan Stanton, Reporter, in-PharmaTechnologist.com and Outsourcing-Pharma.com